Cargando…
Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care
Autologous cell therapy manufacturing timeframes constitute bottlenecks in clinical management pathways of severe burn patients. While effective temporary wound coverings exist for high-TBSA burns, any means to shorten the time-to-treatment with cytotherapeutic skin grafts could provide substantial...
Autores principales: | Chen, Xi, Laurent, Alexis, Liao, Zhifeng, Jaccoud, Sandra, Abdel-Sayed, Philippe, Flahaut, Marjorie, Scaletta, Corinne, Raffoul, Wassim, Applegate, Lee Ann, Hirt-Burri, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536166/ https://www.ncbi.nlm.nih.gov/pubmed/37765300 http://dx.doi.org/10.3390/pharmaceutics15092334 |
Ejemplares similares
-
Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes: Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine
por: Jeannerat, Annick, et al.
Publicado: (2023) -
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care
por: Laurent, Alexis, et al.
Publicado: (2023) -
Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification
por: Philippe, Virginie, et al.
Publicado: (2023) -
Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021) -
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs
por: Chemali, Michèle, et al.
Publicado: (2021)